Nephrology News

The FDA has approved voclosporin as the first oral treatment for lupus nephritis in adult patients who are receiving background immunosuppressive therapy, according to a press release from Aurinia Pharmaceuticals.

A study of patients on maintenance dialysis at a nonprofit national provider showed nearly a 25% mortality rate for those who contracted COVID-19.

Swedish patients who had a stress-related disorder were more likely to experience chronic kidney disease progression and AKI compared with a population-matched control group.

Already commercially available in the United Kingdom, the SC+ portable hemodialysis system from Quanta Dialysis Technologies has received 510(k) clearance “setting the stage for [a] U.S. market launch,” according to a press release.

Contending that diversity among health care professionals is essential to providing the highest quality of care, a speaker at the American Society of Transplant Surgeons Winter Symposium outlined challenges and strategies for improvement.

Kidney care organizations and dialysis providers joined the CDC last week in efforts to assure dialysis clinic and transplant center staff that COVID-19 vaccinations are safe for themselves and their patients.

A quality improvement initiative resulted in increased frequency of peripheral IV placement in the dominant arm for hospitalized children with kidney disease.

Tanuja Chitnis, MD, senior neurologist at Brigham and Women’s Hospital and professor of neurology at Harvard Medical School and coauthor of the new National MS Guidelines, spoke with Healio about autologous hematopoietic stem cell transplant as treatment for MS.

A study comparing the impact of zolpidem and trazodone on patients receiving hemodialysis found zolpidem conferred a higher risk of hospitalization for fall-related fractures.

RenalytixAI and DaVita are collaborating on a program that will use an artificial intelligence-based diagnostic tool to aid in identifying individuals at risk for kidney disease or kidney failure.